It's worth highlighting, though, that poorly controlled diabetes itself elevates the risk of gastroparesis
Guideline Recommendations Figure 3 includes the 2022 American Heart Association/American College of Cardiology/Heart Failure Society of America HF guidelines and the 2023 European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure
Below, we cover how each therapy works, what the research shows about lean mass loss on GLP-1 drugs, how a physician-supervised combination protocol is structured, and what you should know about safety and qualification
On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee (PCAC) is meeting to consider whether certain peptides, including KPV, should be added to the 503A Bulks List, which is a list of drug substances that the FDA has approved for compounding
October 2024 : Acadia Pharmaceuticals received approval from Health Canada for DAYBUE (trofinetide) for the treatment of Rett syndrome, making it the first and only drug approved for this rare neurodevelopmental disorder in the country